EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 31 (3) , 439-444
- https://doi.org/10.1016/s0090-8258(88)80029-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Primary oral etoposide therapy in gestational trophoblastic disease: An updateCancer, 1986
- Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic diseaseGynecologic Oncology, 1986
- Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)BJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumorsGynecologic Oncology, 1984
- Intensive inpatient therapy and survival in gestational trophoblastic diseaseGynecologic Oncology, 1983
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976